• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Cell Impact receives order worth SEK 5.3 million

CIRegulatory press release27.06.2026, 09.33
Download the release

Cell Impact AB (publ) has received an order, worth SEK 5.3 million, from a major PEM fuel cell and electrolyzer OEM based in Northeast USA.

The order relates to the manufacture and supply of existing flow plates already developed and will be used in the customer's established operations. Deliveries are scheduled to take place over the next two years, with the first delivery expected in the third quarter of 2026.

"We are pleased to continue our manufacturing for a customer with whom we have worked for many years. The order serves as a baseline order for future deliveries and covers established products for use in their day-to-day operations. This provides a solid foundation for the efficient manufacturing and a potential for further deliveries," says Daniel Vallin, CEO of Cell Impact.

This information is inside information that Cell Impact AB is obliged to make public pursuant to the EU Market Abuse Regulation.